Pds Biotechnology Corp Stock Price on November 29, 2024
| PDSB Stock | USD 2.14 0.05 2.28% |
Below is the normalized historical share price chart for PDS Biotechnology Corp extending back to September 30, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of PDS Biotechnology stands at 2.14, as last reported on the 11th of December 2024, with the highest price reaching 2.24 and the lowest price hitting 2.08 during the day.
If you're considering investing in PDS Stock, it is important to understand the factors that can impact its price. PDS Biotechnology Corp maintains Sharpe Ratio (i.e., Efficiency) of -0.0834, which implies the firm had a -0.0834% return per unit of standard deviation over the last 3 months. PDS Biotechnology Corp exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check PDS Biotechnology's Market Risk Adjusted Performance of (0.28), risk adjusted performance of (0.05), and Coefficient Of Variation of (1,298) to confirm the risk estimate we provide.
At present, PDS Biotechnology's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 32.5 M, whereas Common Stock Total Equity is forecasted to decline to 7,462. . At present, PDS Biotechnology's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 1.34, whereas Price Earnings Ratio is forecasted to decline to (3.76). PDS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of October 2015 | 200 Day MA 3.41 | 50 Day MA 2.9198 | Beta 1.93 |
PDS |
Sharpe Ratio = -0.0834
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PDSB |
Estimated Market Risk
| 5.14 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.43 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average PDS Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PDS Biotechnology by adding PDS Biotechnology to a well-diversified portfolio.
Price Book 3.7238 | Book Value 0.79 | Enterprise Value 56.8 M | Enterprise Value Ebitda (2.58) | Shares Float 35.4 M |
PDS Biotechnology Main Headline on 29th of November 2024
Acquisition by Bloomquist Delyle W of 10000 shares of PDS Bi... by Bloomquist Delyle W
Filed transaction by PDS Biotechnology Corp Executive. Grant, award or other acquisition pursuant to Rule 16b-3
PDS Biotechnology Valuation on November 29, 2024
It is possible to determine the worth of PDS Biotechnology on a given historical date. On November 29, 2024 PDS was worth 2.19 at the beginning of the trading date compared to the closed value of 2.19. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of PDS Biotechnology stock. Still, in general, we apply an absolute valuation method to find PDS Biotechnology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of PDS Biotechnology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against PDS Biotechnology's related companies.
| Open | High | Low | Close | Volume | |
| 2.11 | 2.25 | 2.10 | 2.15 | 345,414 | |
11/29/2024 | 2.19 | 2.23 | 2.13 | 2.19 | 131,157 |
| 2.21 | 2.30 | 2.13 | 2.15 | 224,599 |
| Backtest PDS Biotechnology | | | PDS Biotechnology History | | | PDS Biotechnology Valuation | Previous | Next |
PDS Biotechnology Trading Date Momentum on November 29, 2024
| On December 02 2024 PDS Biotechnology Corp was traded for 2.15 at the closing time. The top price for the day was 2.30 and the lowest listed price was 2.13 . The trading volume for the day was 224.6 K. The trading history from December 2, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.83% . The trading delta at closing time against the current closing price is 1.37% . |
PDS Biotechnology Corp Fundamentals Correlations and Trends
By evaluating PDS Biotechnology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among PDS Biotechnology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. PDS financial account trend analysis is a perfect complement when working with valuation or volatility modules.About PDS Biotechnology Stock history
PDS Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PDS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in PDS Biotechnology Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing PDS Biotechnology stock prices may prove useful in developing a viable investing in PDS Biotechnology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 31 M | 32.5 M | |
| Net Loss | -36.8 M | -34.9 M |
PDS Biotechnology Quarterly Net Working Capital |
|
PDS Biotechnology Stock Technical Analysis
PDS Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
PDS Biotechnology Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
PDS Biotechnology Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
PDS Biotechnology December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how PDS Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PDS Biotechnology shares will generate the highest return on investment. By undertsting and applying PDS Biotechnology stock market strength indicators, traders can identify PDS Biotechnology Corp entry and exit signals to maximize returns
PDS Biotechnology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for PDS Biotechnology's price direction in advance. Along with the technical and fundamental analysis of PDS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of PDS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (1.20) | |||
| Treynor Ratio | (0.29) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for PDS Stock analysis
When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |